Form D · Venture Capital Fund

Abingworth Bioventures VII LP

London, X0 · CIK 0001688313

Offering snapshot reported May 30, 2018 · SEC filing

Reported sold: $240M
Investors reported: 16
Minimum accepted: $0
First sale: Nov 7, 2016

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$115,513,100 → $240,209,580
Reported investors9 → 16

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 30, 2018	Amendment	$240,209,580	$124,696,480vs Nov 16, 2016	16	SEC filing
Nov 16, 2016	Amendment	$115,513,100	$0vs Nov 15, 2016	9	SEC filing
Nov 15, 2016	Initial	$115,513,100	No comparison	9	SEC filing

Offering details

Securities: Equity, Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $0 (estimated)
Finders' fees: $0
Form D file number: 021-274482

In relation to Items 13 and 14, an aggregate of $151,900,000 has been sold to 16 US investors under Regulation D.

The issuer is required to pay a success fee, based on the aggregate capital subscriptions of the investors in the fund, subject to certain exceptions, plus certain reimbursable expenses of the placement agent.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Asante Capital Group Advisors LLC	155178
Asante Capital Group LLP	None

Source: Form D, filed May 30, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

Each card uses that adviser's latest imported filing. Filing dates can differ; these disclosures do not confirm a current relationship.

Matched by reported Form D file number

ABINGWORTH BIOVENTURES VII LP

Investment adviser: CARLYLE INVESTMENT MANAGEMENT L.L.C.

Gross asset value: $99.9M
Beneficial owners: 64
ADV minimum commitment: $0

Reported in Form ADV on Jul 7, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator APEX GROUP LONDON, United Kingdom Investor statements: Yes (provided to all investors) Related to adviser: No Other funds reporting this name →

Auditor ERNST & YOUNG LLP LONDON, United Kingdom Other funds reporting this name →

Custodian APEX GROUP LONDON, United Kingdom Related to adviser: No Other funds reporting this name →

Custodian BARCLAYS BANK PLC (LONDON) LONDON, United Kingdom Related to adviser: No Other funds reporting this name →

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

ERNST & YOUNG LLP
PCAOB 1438

Fund asset history · 4 annual observations

Scroll to see all columns →

Fiscal year	Gross assets	Beneficial owners	ADV filed
2022	$201,600,000	45	Mar 30, 2023
2023	$368,178,610	46	Mar 27, 2024
2024	$237,805,118	46	Mar 31, 2025
2025	$99,946,272	64	Mar 31, 2026

Filing source

Form ADV 2115592 · Jul 7, 2026 · Schedule D 7.B.(1), fund 805-2889804956

Reported by CARLYLE INVESTMENT MANAGEMENT L.L.C. (CRD 111128).

Other-Than Anual Amendment For Registered Adviser.

Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.

Matched by reported Form D file number

ABINGWORTH BIOVENTURES VII LP

Investment adviser: ABINGWORTH MANAGEMENT INC.

Gross asset value: $304M
Beneficial owners: 44
ADV minimum commitment: $250K

Reported in Form ADV on Oct 31, 2022. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SANNE FIDUCIARY SERVICES (UK) LIMITED LONDON, United Kingdom Investor statements: Yes (provided to all investors) Related to adviser: No Other funds reporting this name →

Auditor DELOITTE LLP LONDON, United Kingdom Other funds reporting this name →

Custodian ROYAL BANK OF CANADA LONDON, United Kingdom Related to adviser: No Other funds reporting this name →

Custodian SANNE FIDUCIARY SERVICES (UK) LIMITED LONDON, United Kingdom Related to adviser: No Other funds reporting this name →

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

DELOITTE LLP
PCAOB 1147

ROYAL BANK OF CANADA
LEI ES7IP3U3RHIGC71XBU11

Fund asset history · 2 annual observations

Scroll to see all columns →

Fiscal year	Gross assets	Beneficial owners	ADV filed
2021	$369,263,000	44	Oct 1, 2021
2022	$304,396,000	44	Sep 2, 2022

Filing source

Form ADV 1674054 · Oct 31, 2022 · Schedule D 7.B.(1), fund 805-2889804956

Reported by ABINGWORTH MANAGEMENT INC. (CRD 157466).

Other-Than Anual Amendment For Registered Adviser.

Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
James Abell	Executive
N/A Abingworth Bioventures Vii Gp Lp	Promoter
N/A Abingworth Llp	Promoter
N/A Abingworth Management Inc	Promoter
Michael Bigham	Promoter
Stephen Bunting	Executive
Shelley Chu	Promoter
Kenneth Haas	Promoter
Timothy Haines	Executive
John Heard	Executive
David Leathers	Director
Genghis Lloyd Harris	Executive
Vincent Miles	Promoter
Kurt Von Emster	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

Princes House 38 Jermyn Street
London, X0, SW1Y 6DN
Phone: 44 207 534 1500